Serosurveillance of viral pathogens circulating in West Africa

Virology Journal

Volumn 13, Issue 1, 2016, Pages 1-6

  O'Hearn, Aileen E ^a   Voorhees, Matthew A ^a   Fetterer, David P ^a   Wauquier, Nadia ^b   Coomber, Moinya R ^c   Bangura, James ^b   Fair, Joseph N ^d   Gonzalez, Jean Paul ^b   Schoepp, Randal J ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b METABIOTA INC   (United States)

^c Kenema Government Hospital   (Sierra Leone)

^d MRIGlobal   (United States)

Author keywords

Alphavirus; Antibodies; Crimean Congo; Ebola; Flavivirus; IgG; Lassa; Luminex; MAGPIX; Marburg; Prevalence; Rift Valley fever; Serosurvey; Sierra Leone; West Africa

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ALPHAVIRUS; ARTICLE; CONTROLLED STUDY; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; DISEASE SURVEILLANCE; EBOLAVIRUS; ENDEMIC DISEASE; FLAVIVIRUS; LASSA VIRUS; LONGITUDINAL STUDY; MARBURGVIRUS; NONHUMAN; RIFT VALLEY FEVER VIRUS; SEROPREVALENCE; SIERRA LEONE; VIRUS INFECTION; BLOOD; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; HUMAN; IMMUNOASSAY; PROCEDURES; SEROEPIDEMIOLOGY; VIROLOGY; VIRUS DISEASES;

ANTIBODIES, VIRAL; DISEASE OUTBREAKS; ENDEMIC DISEASES; EPIDEMIOLOGICAL MONITORING; HUMANS; IMMUNOASSAY; SEROEPIDEMIOLOGIC STUDIES; SIERRA LEONE; VIRUS DISEASES;

EID: 84990829379     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-016-0621-4     Document Type: Article

References (35)

1. Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, et al. Lassa Fever in Post-Conflict Sierra Leone. PLoS Negl Trop Dis. 2014;8(3):e2748.
2. Frame JD, Baldwin Jr JM, Gocke DJ, Troup JM. Lassa Fever, a new virus disease of man from West Africa 1. Clinical Description and Pathological Findings. 1970;19(4):670-6.
3. Leifer E, Gocke DJ, Bourne H. Lassa Fever, A New Virus Disease of Man from West Africa 2. Report of a Laboratory-Acquired Infection Treated with Plasma from a Person Recently Recovered from the Disease. Am J Trop Med Hyg. 1970;19(4):677-9.
4. Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg. 1970;19(4):680-91.
5. Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis. 2014;20(7):1176-82.
6. Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, et al. Multiple Circulating Infections Can Mimic the Early Stages of Viral Hemorrhagic Fevers and Possible Human Exposure to Filoviruses in Sierra Leone Prior to the 2014 Outbreak. Viral Immunol. 2015;28(1):19-31.
7. Auperin DD, McCormick JB. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology. 1989;168(2):421-5.
8. Auperin DD, Sasso DR, McCormick JB. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology. 1986;154(1):155-67.
9. Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl):S177-87.
10. Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med Nature Publishing Group. 2010;16(9):991-4.
11. Meegan JM. The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies. Trans R Soc Trop Med Hyg. 1979;73(6):618-23.
12. Causey OR, Kemp GE, Madbouly MH, David-West TS. Congo virus from domestic livestock, African hedgehog, and arthropods in Nigeria. Am J Trop Med Hyg. 1970;19(5):846-50.
13. Sabin AB, Schlesinger RW. Production of immunity to dengue with virus modified by propagation in mice. Science. 1945;101(2634):640-2.
14. Sabin AB. The dengue group of viruses and its family relationships. Bacteriol Rev. 1950;14(3):225-32.
15. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 1999;286(5448):2333-7.
16. Theiler M. The virus. In: Yellow Fever. 1951. p. 39-136.
17. Monath TP, Schlesinger JJ, Brandriss MW, Cropp CB, Prange WC. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence. Am J Trop Med Hyg. 1984;33(4):695-8.
18. Schmaljohn AL, Kokubun KM, Cole GA. Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein. Virology. 1983;130(1):144-54.
19. SAS Institute Inc. SAS 9.4 Statements Reference, Fourth Edition. Cary, NC: SAS Institute Inc.; 2015.
20. Mccormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A Prospective Study of the Epidemiology and Ecology of Lassa Fever. J Infect Dis. 1987;155(3):437-44.
21. Favier C, Chalvet-Monfray K, Sabatier P, Lancelot R, Fontenille D, Dubois MA. Rift Valley fever in West Africa: the role of space in endemicity. Trop Med Int Health. 2006;11(12):1878-88.
22. Fontenille D, Traore-Lamizana M, Zeller H, Mondo M, Diallo M, Digoutte JP. Short report: Rift Valley fever in western Africa: isolations from Aedes mosquitoes during an interepizootic period. Am J Trop Med Hyg. 1995;52(5):403-4.
23. Fontenille D, Traore-Lamizana M, Diallo M, Thonnon J, Digoutte JP, Zeller HG. New vectors of Rift Valley fever in West Africa. Emerg Infect Dis. 1998;4(2):289-93.
24. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64(3):145-60.
25. Appannanavar SB, Mishra B. An update on crimean congo hemorrhagic Fever. J Glob Infect Dis. 2011;3(3):285-92.
26. Messina JP, Pigott DM, Golding N, Duda KA, Brownstein JS, Weiss DJ, et al. The global distribution of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg. 2015;109(8):503-13.
27. Gonzalez JP, LeGuenno B, Guillaud M, Wilson ML. A fatal case of Crimean-Congo haemorrhagic fever in Mauritania: virological and serological evidence suggesting epidemic transmission. Trans R Soc Trop Med Hyg. 1990;84(4):573-6.
28. Fagbami AH, Monath TP, Fabiyi A. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg. 1977;71(1):60-5.
29. Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011;17(8):1349-54.
30. Kuniholm MH, Wolfe ND, Huang CY-H, Mpoudi-Ngole E, Tamoufe U, Burke DS, et al. Seroprevalence and distribution of flaviviridae, togaviridae, and bunyaviridae arboviral infections in rural Cameroonian adults. Am J Trop Med Hyg. 2006;74(6):1078-83.
31. Pezzoli L, Conteh I, Kamara W, Gacic-Dobo M, Ronveaux O, Perea WA, et al. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009. BMC Public Health BioMed Central. 2012;12(1):415.
32. Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, et al. Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data. Hay SI, editor. PLoS Med. Public Library of Science; 2014 May 6;11(5):e1001638.
33. Posey DL, O'rourke T, Roehrig JT, Lanciotti RS, Weinberg M, Maloney S. O'nyong-nyong fever in West Africa. Am J Trop Med Hyg. 2005;73(1):32.
34. Jentes ES, Robinson J, Johnson BW, Conde I, Sakouvougui Y, Iverson J, et?al. Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg. 2010;83(2):388-94.
35. Ansumana R, Jacobsen K, Leski T, Covington A, Bangura U, et al. Reemergence of Chikungunya Virus in Bo, Sierra Leone. Emerg Infect Dis. 2013;19(7):1108-10.